NeuroPace (NPCE) Competitors $10.82 +0.34 (+3.24%) Closing price 04:00 PM EasternExtended Trading$10.92 +0.09 (+0.88%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NPCE vs. SSII, PLSE, KMTS, BLFS, ESTA, MDXG, TNDM, BBNX, INMD, and IRMDShould you be buying NeuroPace stock or one of its competitors? The main competitors of NeuroPace include SS Innovations International (SSII), Pulse Biosciences (PLSE), Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Tandem Diabetes Care (TNDM), Beta Bionics (BBNX), InMode (INMD), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry. NeuroPace vs. Its Competitors SS Innovations International Pulse Biosciences Kestra Medical Technologies BioLife Solutions Establishment Labs MiMedx Group Tandem Diabetes Care Beta Bionics InMode iRadimed SS Innovations International (NASDAQ:SSII) and NeuroPace (NASDAQ:NPCE) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations. Does the media refer more to SSII or NPCE? In the previous week, SS Innovations International had 1 more articles in the media than NeuroPace. MarketBeat recorded 6 mentions for SS Innovations International and 5 mentions for NeuroPace. NeuroPace's average media sentiment score of 0.77 beat SS Innovations International's score of 0.63 indicating that NeuroPace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeuroPace 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of SSII or NPCE? 78.8% of NeuroPace shares are owned by institutional investors. 20.5% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is SSII or NPCE more profitable? NeuroPace has a net margin of -29.29% compared to SS Innovations International's net margin of -40.20%. SS Innovations International's return on equity of -40.41% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets SS Innovations International-40.20% -40.41% -20.80% NeuroPace -29.29%-168.61%-25.48% Which has preferable earnings & valuation, SSII or NPCE? SS Innovations International has higher earnings, but lower revenue than NeuroPace. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSS Innovations International$20.65M85.22-$19.15MN/AN/ANeuroPace$88.57M4.04-$27.14M-$0.84-12.88 Do analysts recommend SSII or NPCE? NeuroPace has a consensus price target of $16.60, suggesting a potential upside of 53.42%. Given NeuroPace's stronger consensus rating and higher probable upside, analysts plainly believe NeuroPace is more favorable than SS Innovations International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SS Innovations International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00NeuroPace 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 SummaryNeuroPace beats SS Innovations International on 8 of the 13 factors compared between the two stocks. Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NPCE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NPCE vs. The Competition Export to ExcelMetricNeuroPaceMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$357.94M$6.90B$6.02B$10.45BDividend YieldN/A1.19%5.73%4.82%P/E Ratio-12.8826.7985.1227.24Price / Sales4.0427.69589.92133.47Price / CashN/A21.8525.7730.18Price / Book40.075.1812.676.76Net Income-$27.14M$178.09M$3.32B$276.59M7 Day Performance1.60%-1.21%0.50%0.86%1 Month Performance9.74%7.96%9.42%8.17%1 Year Performance67.49%4.75%79.11%43.66% NeuroPace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NPCENeuroPace3.6728 of 5 stars$10.82+3.2%$16.60+53.4%+58.5%$357.94M$88.57M-12.88170News CoverageSSIISS Innovations InternationalN/A$6.80-5.4%N/AN/A$1.39B$20.65M0.004Gap UpPLSEPulse Biosciences3.7837 of 5 stars$19.45+0.8%$22.00+13.1%+1.5%$1.30B$700K-18.52140KMTSKestra Medical Technologies1.495 of 5 stars$25.03+0.8%$27.33+9.2%N/A$1.28B$59.81M0.00300BLFSBioLife Solutions2.0061 of 5 stars$26.52-0.3%$31.29+18.0%+21.3%$1.27B$82.25M-220.98440ESTAEstablishment Labs2.7734 of 5 stars$39.33-5.1%$56.50+43.7%+3.3%$1.20B$166.02M-12.901,018News CoverageAnalyst DowngradeMDXGMiMedx Group3.4462 of 5 stars$7.31+1.4%$12.00+64.2%+14.0%$1.07B$348.88M34.81870High Trading VolumeTNDMTandem Diabetes Care4.2187 of 5 stars$15.01+2.0%$22.44+49.5%-62.6%$993.95M$940.20M-4.862,650BBNXBeta Bionics1.7813 of 5 stars$21.95-1.4%$24.44+11.4%N/A$967.65M$65.12M0.00294INMDInMode2.6828 of 5 stars$15.23+0.5%$18.04+18.5%-7.3%$957.62M$394.82M6.17480Positive NewsIRMDiRadimed4.5844 of 5 stars$71.76+0.7%$72.00+0.3%+43.6%$905.82M$77.64M44.30110Insider Trade Related Companies and Tools Related Companies SS Innovations International Alternatives Pulse Biosciences Alternatives Kestra Medical Technologies Alternatives BioLife Solutions Alternatives Establishment Labs Alternatives MiMedx Group Alternatives Tandem Diabetes Care Alternatives Beta Bionics Alternatives InMode Alternatives iRadimed Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NPCE) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
